Evidence map›Paper›PMID 40249552›Full record

ArticleAbdominal radiology (New York)2025

Machine learning-based multiparametric CT radiomics for predicting microvascular invasion before nephrectomy in clear cell renal cell carcinoma.

Jinbin Xu, Shuntian Gao, Qin Zhu, Fuyang Dai, Ciming Sun, Weijen Lee, Yuedian Ye, Gengguo Deng, Zhansen Huang, Xiaoming Li and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jinbin XuThird Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Shuntian GaoThird Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Qin ZhuFirst Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Fuyang DaiSecond Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Ciming SunSun Yat-sen University Cancer Center, Guangzhou, China.
Weijen LeeThird Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Yuedian YeThird Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Gengguo DengThird Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Zhansen HuangThird Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Xiaoming LiThird Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Jiang LiThird Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Samun CheongThird Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Qunxiong HuangThird Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. hqx7374@163.com.
Jinming DiThird Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. dijinm@mail.sysu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to investigate the value of integrating computed tomography (CT)-based tumor radiomics features with clinical parameters for preoperative prediction of microvascular invasion (MVI) in clear cell renal cell carcinoma (ccRCC).

methodsWe retrospectively analyzed data from a single-center cohort of ccRCC patients. Radiomics features were extracted from preoperative multiphasic CT scans (unenhanced, corticomedullary, and nephrographic phases). Following dimensionality reduction and feature selection, eight machine learning algorithms were evaluated to identify the optimal radiomics model. Independent clinical predictors were determined through univariate and multivariate analyses. A nomogram integrating the radiomics signature (rad-score) with significant clinical parameters was subsequently developed. Model performance was assessed using the area under the curve (AUC), decision curve analysis (DCA), and calibration curve analysis (CAC).

resultsOf 143 initially enrolled patients, 110 met inclusion criteria after screening, with 5502 radiomics features extracted. The support vector classifier (SVM) model demonstrated the highest discriminative ability, achieving mean AUCs of 0.976 (training cohort) and 0.892 (test cohort), significantly outperforming the clinical model (training AUC = 0.935, test AUC = 0.933). The nomogram showed superior diagnostic performance, with AUCs of 0.958 (test). DCA and CAC confirmed its clinical utility and robustness.

conclusionsMultiparametric CT radiomics models enable non-invasive prediction of MVI status in ccRCC, with the SVM-based algorithm showing optimal performance. The integrated nomogram provides excellent and consistent diagnostic accuracy, offering a valuable preoperative tool for clinical decision-making.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsMachine LearningTomography, X-Ray ComputedAdultAgedFemaleHumansMaleMicrovesselsMiddle AgedNeoplasm InvasivenessNephrectomyNomogramsPredictive Value of TestsRadiographic Image Interpretation, Computer-AssistedClear cell renal cell carcinomaComputed tomographyMicrovascular invasionRadiomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.